Inventor
DALI MANDAR V
US14 patents
⚠️ This page may combine multiple inventors who share the name “DALI MANDAR V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
8 patentsUS7851502B2Dec 14, 2010
Pharmaceutical formulations containing an SGLT2 inhibitor
BRISTOL MYERS SQUIBB CO57 citations96
US6670344B2Dec 30, 2003
Combretastatin A-4 phosphate prodrug mono- and di-organic amine salts, mono- and di- amino acid salts, and mono- and di-amino acid ester salts
BRISTOL MYERS SQUIBB CO33 citations90
US8716251B2May 6, 2014
Pharmaceutical formulations containing an SGLT2 inhibitor
BRISTOL MYERS SQUIBB CO8 citations82
US8361972B2Jan 29, 2013
Pharmaceutical formulations containing an SGLT2 inhibitor
BRISTOL MYERS SQUIBB CO10 citations82
US6855702B2Feb 15, 2005
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts
BRISTOL MYERS SQUIBB CO14 citations82
US7659262B2Feb 9, 2010
Combretastatin A-4 phosphate prodrug mono- and di-organic amine salts, mono- and di-amino acid salts, and mono- and di-amino acid ester salts
BRISTOL MYERS SQUIBB CO1 citations60
US7659261B2Feb 9, 2010
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts
BRISTOL MYERS SQUIBB CO0 citations50
US7524832B2Apr 28, 2009
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts and mono-and di-amino acid ester salts
BRISTOL MYERS SQUIBB CO0 citations50
PTC THERAPEUTICS INC
4 patentsUS9873677B2Jan 23, 2018
Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
PTC THERAPEUTICS INC8 citations82
US10618877B2Apr 14, 2020
Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
PTC THERAPEUTICS INC0 citations51
US10233161B2Mar 19, 2019
Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
PTC THERAPEUTICS INC0 citations51
US11786486B2Oct 17, 2023
Pharmaceutical compositions comprising 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione
PTC THERAPEUTICS INC0 citations41